Taking everything into account, UnitedHealth Group Incorporated (NYSE:UNH) scores 56.% Buy on the technical side. The stock is also flashing a Buy from the Barchart TrendSpotter trading system. Traders hoping to speculate on the UNH’s short-term trajectory should know that short terms indicators for the stock averaged 60% Buy with an average daily trading volume over the past 20 days at 3404415 shares. UNH stock has overall a 0.25% Buy signal considering medium term indicators and the 50-day average daily volume remained almost 3409736 shares. It’s also worth noting that the stock, whose average daily volume over the 100 days prior to this writing was shares, is 67% Buy on the basis of long term indicators.
The share price is currently staying around the first support level of $263.67. Below this, the next support is placed in the zone of $261.19. Till the time, the UNH stock trades above this level, bulls have nothing to fear. On momentum oscillators front, ‘RSI’ has touched 51.07 on daily chart, which may remain a cause for concern. If the price breaks below $261.19 level on closing basis, then we may see more profit booking and the stock may show further weakness. On the flipside, hitting the $268.47 mark may result into a pull-back move towards $270.79 level.
UnitedHealth Group Incorporated (UNH) is projected to climb by 15.41 percent over the next 12 months, according to price target estimates compiled by finviz. Meanwhile, they have set a $330 as 1-year high price target. This represents a whopping 23.99 percent increase from where shares are trading today. The 12-month median price target assigned by the analysts stands at $308, which represents a return potential of 15.72 percent when compared to the closing price of the stock of $266.16 on Monday, November 26. The lowest price target for the stock is $218 — slightly more than -18.09 percent from UNH’s current share price.
Here’s a rundown of insider trading activity for sense of UnitedHealth Group Incorporated (NYSE:UNH). The earliest insider trade took place on 11/09/2018. Shine Kenneth Irwin parted with a total of 0.16 thousand shares of company at average share price of $274.83. The total for the sales was set at $44.8 thousand. After this transaction, the Director account balance stood at 29.15 thousand shares. The stock lost -3.15 percent since that insider sale. On 09/13/2018, Nelson Steven H, EVP & CEO, UnitedHealthcare, sold 8.14 thousand shares at a price per share of $265. This removed 2.16 million shares from the insider’s fortune and the stock saw a 0.44 percent rally in value since the news became public. This transaction left 22.5 thousand shares in the EVP & CEO, UnitedHealthcare account. On 09/13/2018, Director Burke Richard T performed a sale transaction worth $2.65 million. This sale at $264.9 each has eliminated 10 thousand shares from the insider’s portfolio position. Meanwhile, shares have recorded 0.48 percent increase since the transaction was reported. The insider now is left with 1.8 million shares remaining in the account. Hooper Michele J, who performs the Director job, sold 5 thousand shares for $1.32 million. The disposal occurred on 09/13/2018 was priced at $264.86 per share. The share price soared 0.49 percent since the reporting date. Hooper Michele J now left with a stake of 32.87 thousand UNH stock worth $8.75 million after the insider selling.
UNH shares accumulated 4.54 points or 1.74 percent on Monday to $266.16 with a heavy trade volume of 3.617 million shares. After opening the session at $264.62, the shares went as high as $268.3 and as low as $263.4981, the range within which the stock’s price traded throughout the day. The firm is left with a market cap of $255 billion and now has 958.1 million shares outstanding. UnitedHealth Group Incorporated (UNH) stock has gained 0.73 percent of market value in 21 trading days.
Analysts at Citigroup cut their rating on shares of UnitedHealth Group Incorporated (NYSE:UNH) from Buy to Neutral in their opinion released on September 10.
UNH stock has a trailing 3-year beta of 0.76, offering the possibility of a lower rate of return, but also posing less risk. The portion of a company’s profit allocated to each outstanding share of common stock was $11.53 a share in the trailing twelve months. The stock’s value has surged 20.73 percent year to date (YTD) against a rise of 25.25 percent in 12 month’s time. The company’s shares still trade -4.26 percent away from its 1-year high of $278.00 and 27.67 percent up from 52-week low of $208.48. The average consensus rating on the company is 1.6, on a scale where 5 equates to a unanimous sell rating. In short, the mean analyst recommendations are calling this stock a buy.
Shares of UnitedHealth Group Incorporated (UNH) are trading at a P/E ratio of 23.35 times earnings reported for the past 12 months. The industry UNH operates in has an average P/E of 23.05. Its P/E ratio went as low as 13.69X and as high as 23.21 over the 5-year span. Further, it is sporting a 1.16 on the Price-to-Sales ratio. Compare this with the industry average P/S of 1.03. 0 percent is the gross profit margin for UnitedHealth Group Incorporated and operating margin sits at 7.7 percent. Along with this, the net profit margin is 5.7 percent.
UNH will be declaring its Q4 financial results on January 15. Analysts are forecasting revenue to climb 11.3 percent to $57.9B in the next fiscal quarter, while earnings are seen soaring by nearly 23.94 percent to $3.21 per share. History has shown that shares in UnitedHealth Group Incorporated have gone up on 18 different earnings reaction days and are predicted to add 0.02 percent when the company reports upcoming earnings. In last reported earnings results, it earned $3.41 per share, better than the $3.29, adjusted, expected by Thomson Reuters consensus estimate. Revenue was $56.6B, better than the $56.3B analysts expected. Earnings are estimated to increase by 31.1 percent this year, 13.74 percent next year and continue to increase by 15.8 percent annually for the next 5 years.